文
论文分享
演练场
杂货铺
论文推荐
字
编辑器下载
登录
注册
H. Li
发表
nab-Paclitaxel plus carboplatin or gemcitabine versus gemcitabine plus carboplatin as first-line treatment of patients with triple-negative metastatic breast cancer: results from the tnAcity trial
A. Schneeweiss, N. Harbeck, J. Cortes, 2018, Annals of oncology : official journal of the European Society for Medical Oncology.